We investigated endoproteolytic processing of the human immunodeficiency virus (HIV) envelope glycoprotein precursor, gpl60, as well as envelopemediated membrane fusion in the presence of CD4 molecules that were either partially or fully retained in the endoplasmic reticulum (ER). Pulse-chase analyses revealed that gpl60 formed complexes with CD4 molecules, and gpl60 in the complex was endoproteolyticaUy cleaved to gpl20 and gp41 in the secretory pathway. The gpl20/gp41 complex thus generated was properly targeted to the plasma membrane in cells expressing gpl60 and wild-type CD4 or mutant CD4 molecules that were partially retained in the ER. Additionally, membrane fusion (syncytium) assays were performed to monitor the presence or absence of gpl20/gp41 complexes at the cell surface of cotransfected cells and demonstrated that the HIV-1 envelope glycoprotein-mediated membrane fusion was appreciably reduced in the presence of wild-type CD4 or either one of the mutant CD4 molecules. Reduction in the formation of syncytia appears to be due predominantly to saturation of the CD4 binding site on the gpl20/gp41 complex at the cell surface of cotransfected cells, but partial retention of the complex in the ER could also partly account for the reduction. However, the intracellular gpl20/gp41 complex generated in cells expressing gpl60 and CD4 mutant having the transmembrane ER retention signal (KKTC) was completely retained in the ER and hence could not participate in membrane fusion events at the plasma membrane. Taken together, these data suggest that the endoproteolytic cleavage ofgp 160 occurs in the ER or cis-Golgi network, and ER retention strategies can potentially be used in preventing the spread of HIV-1 infection in permissive cells.
Introduction
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of AIDS. It is a complex retrovirus whose genome encodes a number of novel regulatory and accessory proteins in addition to the structural proteins gag, pol and env that are common to all retroviruses (Haseltine, 1991; Cullen, 1992) . The envelope glycoprotein precursor, gpl60, encoded by the env gene of HIV-1, plays a central role in cell tropism and pathogenicity (Lifson et al., 1986; Sodroski et al., 1986; Kowalski et al., 1987; Lifson & Engleman, 1989; Haseltine, 1991; Hwang et al., 1991; Page et al., 1992; Levy, 1993) . The gpl60 undergoes endoproteolytic cleavage to generate gpl20/gp41 oligomers in the secretory pathway of mammalian cells (McCune et al., 1988; Willey et al., 1988; Gou et al., 1990; Freed et al., 1990; Earl et al., 1990 Earl et al., , 1991 . The gpl20/gp41 complex binds to the major receptor for HIV, CD4, with high affinity at the cell surface, and initiates membrane fusion reactions to establish productive infection in susceptible cells (Dalgleish et al., 1984; Klatzmann et al., 1984; McDougal et al., 1986; Lifson et aL, 1986; Sodroski et al., 1986; Maddon et al., 1986; Kowalski et al., 1987) . Genetic and biochemical analyses have revealed that the N-terminal portion of CD4 is involved in binding to the HIV envelope glycoprotein (Lifson & Engleman, 1989; Capon & Ward, 1991; Eiden & Lifson, 1992) , whereas the cytoplasmic domain of CD4 contains information for the intracellular membrane trafficking and signal transduction pathway (Shin et al., 1990 (Shin et al., , 1991 Shaw et al., 1990; Turner et al., 1990; Gleichenhause et al., 1991) . However, the CD4 tail was not necessary for the establishment of productive HIV infection in permissive cells (Bedinger et al., 1988; Maddon et al., 1988) .
The cell surface expression of CD4 was greatly reduced in HIV-infected cells, but the mechanism was not clearly understood (Dalgleish et al., 1984; Klatzmann et al., 0001-1770 0001- © 1993 0001- SGM 1984 Hoxie et al., 1986) . However, a number of studies suggest that the structural, regulatory and accessory proteins of HIV-1 might play distinct roles in the downregulation of CD4 (Stevenson et al., 1988; Kawamura et al., 1989; Crise et al., 1990; Jabbar & Nayak, 1990; Garcia & Miller, 1990; Bour et al., 1991; Butera et al., 1991; Willey et al., 1992a) . We and others have demonstrated that the HIV-1 gpl60 could bind CD4 with high affinity in the endoplasmic reticulum (ER), thereby preventing the delivery of CD4 to the plasma membrane (Kawamura et al., 1989; Crise et al., 1990; Jabbar & Nayak, 1990; Bour et aL, 1991 ; Willey et aL, 1992a) . Furthermore, the HIV-1 Nef protein has been shown to down-regulate CD4 from the cell surface by mechanism(s) not clearly understood at present, but requiring the cytoplasmic domain of CD4 to exert its effects in a species-independent manner (Garcia & Miller, 1990; Garcia et al., 1993) . Also, recent studies have elucidated that one of the HIV-1 accessory proteins, Vpu, induced the degradation of CD4 molecules trapped in the ER (Willey et al., 1992b; Vincent et aL, 1993) . Thus, HIV-1 employs a number of strategies to prevent the expression of CD4 at the plasma membrane, but the role of CD4 down-regulation in HIV immunopathogenesis is unclear (Rosenberg & Fauci, 1991; Levy, 1993) . However, the reduced expression of CD4 at the cell surface might be very important in the superinfection interference of homologous virus infections in HIVinfected cells (Stevenson et al., 1988 (Stevenson et al., , 1992 Levy, 1993) .
Specific retention signals have been identified for both luminal and transmembrane proteins of the ER (Nilsson et al., 1989; Pelham, 1989; Jackson et al., 1990) . Furthermore, it has been shown that the luminal (KDEL) and transmembrane ER retention (KKXX or XKXX) signals were sufficient and necessary to retain heterologous soluble and membrane-anchored proteins, respectively, in the ER (Nilsson et al., 1989; Munro & Pelham, 1987; Buonocore & Rose, 1990; Shin et al., 1991 a; Lee & Donoghue, 1992) . Recently, Buonocore & Rose (1990 have demonstrated that the expression of soluble CD4 (sCD4) KDEL in CD4 + T cells or HeLa blocked the transport of gp120/gp41 complexes to the cell surface, and the T cells expressing sCD4~KDEL could not produce infectious virus particles, thereby preventing virus spread in HIV-infected cultures. Thus the ER retention approach might be potentially useful for the design of gene therapy strategies to control the world-wide AIDS epidemic.
In the present study, we have analysed the endoproteolytic cleavage of gpl60, as well as envelope-mediated membrane fusion in the presence of wild-type (wt) or mutant CD4 molecules bearing the transmembrane ER retention signals. Coexpression studies revealed that the gpl60 formed complexes in the ER with wt CD4 and other CD4 mutants having partial ER retention signals. Furthermore, the gpl60 in the complex was able to undergo endoproteolytic cleavage generating gpl20 and gp41, and gpl20 was shed into the extracellular medium. We also present evidence that the gpl20/gp41 complex at the cell surface of cotransfected cells was not able to engage effectively in membrane fusion reactions, perhaps due to saturation of the CD4-binding sites or reduced expression of the gp120/gp41 complex at the plasma membrane. However, the gp 120/gp41 complex generated in cells expressing gp160 and CD4 having the ER retention signal (KKTC) was not transported to the plasma membrane. Consequently, it could not participate in membrane fusion events in HeLa CD4 + cells.
Methods
Cells, virus and expression plasmids. The recombinant vaccinia virus, vTF7-3, which synthesizes T7 RNA polymerase in infected cells (Fuerst et al., 1987) was used for the expression studies. The genes encoding HIV-1 envelope glycoproteins and CD4 molecules were cloned behind the T7 promoter, respectively in pGEM-3 (Promega) and in pcDNA[ (Invitrogen). HeLa and HeLa T4 cells expressing the human CD4 molecule were employed in transfection experiments. HeLa T4 cells (Maddon et al., 1986) were maintained and propagated in the presence of G418 (1 mg/ml) in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % newborn calf serum.
PCR mutagenesis of the gene encoding CD4 and the HIV gpl60. The plasmids pGenv-7 and pGCD4 (Jabbar & Nayak, 1990) were used as the templates to generate gpl20 and the CD4 mutants. The primers were made by Operon Technologies. PCR mutagenesis of the cDNA encoding CD4 was performed using the primers shown below; one of the primers (EcoUP) was a common primer having the EeoRI site and the other three were deletion primers having the XbaI site: 5' GACCGGAATTCAAGCCCAGAGCC 3' (EcoUP), 5' GACGC-TCTAGATTAGCAGGTCTTCTTCTC 3' (K-3), 5' GACGCTCT-AGATTAGGTCTTCTTCTCACT 3' (K-2) and 5 / GACGCTCT-AGATTAGAGTCTCTTGATCTG 3' (K-l). PCR amplifications were done in 100 pl reactions containing 100 ng each of the template, pGCD4 or pGEnv-7, and the primers (250 nM each), 5 units of Taq polymerase (1 I~1), 10 mu-dNTPs (2 gl), 10 x buffer (10 lal). The reactions were done in 25 cycles using a Thermal Cycler (Perkin-Elmer Cetus) in the sequence shown: 7 rain at 94 °C; 2 min at 94 °C; 2 min at 50 °C; 1 rain at 72 °C. Extension of the PCR product was carried out at 72 °C for 5 min and the reaction mix was kept at 4 °C before being analysed on the gel. Reagents for the PCR reactions were purchased from Boehringer Mannheim. The PCR products were cut with EcoRI and XbaI, and the CD4 fragments were cloned into pcDNAI, which was cut with the corresponding enzymes. Expression plasmids encoding the mutant CD4 molecules were named pcDN-CD4K1, pcDN-CD4K2 and pcDN-CD4K3.
To generate pGgpl20, the gene segment was amplified as an NdeI-XbaI DNA fragment using the primers shown below and the template pGenv-7 (Jabbar & Nayak, 1990) , and the DNA fragment was ligated to the expression vector pGenv-7 that had been cut with the enzymes NdeI and XbaI. All the clones were sequenced using Sequenase in dideoxynucleotide sequencing reactions (United States Biochemical) to verify mutations and to ensure functional genes were intact. The gp120 generated for this study has 470 amino acids (aa) ending with KAKRR as the last five. The bold letters denote restriction sites in its were infected with vTF7-3 at an m.o.i, of 10, and infection was carried out for 1 h in a CO 2 incubator at 37 °C with occasional rocking (every 15 rain) of the dishes. At the end of the incubation period, the virus inoculum was removed and the cells were washed once with PBS containing Ca 2+ and Mg 2+ (Dulbecco's buffer). The DNA-lipofectin mix was prepared during the infection period as follows: plasmid DNAs (5 to 10 lag) and 10 lal of lipofectin (BRL) were added separately to 0.1 ml each of opti-MEM in polystyrene tubes, mixed together for 15rain before being added to 0.8ml of fresh opti-MEM. The DNA lipofectin mix was then layered onto infected cells and incubated for an additional 3 h under 5 % CO~. At 3 h post-transfection, 1 ml of DMEM containing 10% fetal bovine serum was added to the dishes and incubation continued for an additional 12 h at 37 °C in the CO n incubator.
Immunodetection of the glycoproteins in transfected HeLa cells.
Indirect immunofluorescence (IF) was performed to analyse expression of the HIV envelope glycoproteins and CD4 as follows. HeLa cells were grown on glass coverslips and transfeeted as described above. For cell surface labelling, the transfected cells were fixed in 3.7 % formaldehyde for 10 min at room temperature, whereas the formaldehyde-fixed cells were permeabilized with 1% NP40 for 5 rain to localize the proteins in the intracellular compartment. Five lal of the OKT4 antibody (anti-CD4 antibody, 250 ng/ml; Orthodiagnostics) was added to the cells and incubated for 30 min at room temperature. The antibody was removed and washed with cold PBS three or four times before adding the FITC-conjugated anti-mouse second antibodies (1 : 100). The cells were incubated with the second antibody for 30rain, washed thoroughly, and mounted in 80% glycerol containing 0.1% pphenylenediamine (an anti-bleach agent; Sigma). For the detection of gpl20 or gpl20/gp41 complexes in the cell, the transfected HeLa cells were processed similarly, but the anti-gpl20sve antibody (1:500) and FITC-conjugated anti-goat antibody were used to reveal the HIV envelope glycoproteins in the intracellular compartment and at the cell surface. Fluorescing cells were photographed at x 100 using a Zeiss Inverted Axioscope.
Metabolic labelling, immunoprecipitation, endoglycosidase-treatrnent and densitometry. The transfected HeLa cells were washed twice with PBS and starved for 1 h in DMEM lacking serum, methionine and cysteine. The cells were pulse-labelled for 30 rain with 100 laCi/ml of ass Translabel (ICN Biomedicals; 1200 Ci/mmol, 0.5 ml of the labelling mix) and chased at different times in the presence of excess unlabelled methionine and cysteine. The radiolabelled cells were lysed in 0-5 ml of RIPA buffer (Jabbar & Nayak, 1987) on ice and lysates were clarified by centrifugation at 12000 r.p.m, for 10 rain in the cold. The clarifed cytoplasmic lysates were incubated with the appropriate antibody for 90 min on ice. Protein A-Sepharose (5 rag) was added to antige~ antibody complexes and mixed by shaking them in the cold room for 90 min. After extensive washing in buffers containing high salt and BSA, the immunoprecipitates were treated with endoglycosidase (Endo-H), and an equal portion was left untreated as described previously (Jabbar & Nayak, 1990) . To monitor gpl20 shedding from cotransfected cells, media were collected and centrifuged at 1500 r.p.m. for 15 to 30 min using Centricon-30 concentrators (Amicon) before being immunoprecipitated with the anti-gpl20 antibody. Endo-Htreated and untreated protein samples were resolved by 8% SDS-PAGE and fluorography was performed as described (Jabbar & Nayak, 1990) . The glycoproteins were quantified by scanning the auloradiograms (Kundu et al., 1991) in a densitometer scanner (Bio-Rad Model 620).
Syncytium assays. HeLa T4 cells were seeded onto 35 mm six-well plates (Costar) in the absence of G418 2 days prior to transfection.
For syncytium assays, plasmids encoding gpl60 (5 gg) alone or in combination with those (5 gg each) expressing one of the CD4 proteins (wt CD4, CD4K1, CD4K2 and CD4K3) were transfected into HeLa T4 cells, and syncytia were observed at 15 to 20 h posttransfection. Syncytia were photographed using Polaroid 55 or 57 fihns at x 20 in a phase contrast microscope (Olympus).
Results

Expression of wild-type and mutant CD4 proteins
We generated three CD4 mutants that have deletions in the cytoplasmic domain (Fig. 1) . One of the mutants (CD4K3) has a tetrapeptide sequence (KKTC) at the carbo×yl terminus due to a 13 aa deletion in the cytoplasmic domain. The other CD4 mutants, CD4K2 and CD4K1, have deletions of 14 and 20 aa, respectively, in the cytoplasmic domains, and these CD4 molecules have either E KKT or IKRL at the COOH terminus. Plasmids encoding the wt and mutant CD4 molecules were transfected into HeLa cells for analysis of the expression of CD4 molecules in the cell. The transfected cells were fixed in 3.7% formaldehyde to reveal the presence of CD4 molecules at the cell surface, and the fixed cells were permeabilized with 1% NP40 to localize the proteins in the intracellular compartment, as described in Methods. The OKT4 antibody labelled wt and mutant CD4 molecules, wt CD4, CD4K1 and CD4K2, at the plasma membrane ( Fig. 2 a, c, e) and in the intracellular membrane compartment (Fig. 2b, d ,f). Moreover, the intracellular staining indicated that the CD4 molecules were localized in the perinuclear region of the cell, presumably the Golgi apparatus. However, there was little or no delivery of CD4K3 to the cell surface ( Fig. 2g ), but it was present abundantly in the intracellular compartment (Fig. 2h) . Furthermore, the intracellular staining was qualitatively different from (Maddon et al., 1985) were generated by PCR mutagenesis as described in Methods. Positions of the lysine residues (--3, or -3 and -4) in the cytoplasmic domains are counted from the carboxyl terminus (Jackson et al., 1990) . that revealed in cells expressing wt CD4, CD4K1 or CD4K2 (Fig. 2b, d ,f), and showed a reticular pattern indicating that CD4K3 was retained very efficiently in the ER. Thus, wt and mutant CD4 proteins were expressed in HeLa cells using the recombinant vaccinia virus-T7 RNA polymerase expression system.
Intracellular transport of wt CD4 and the gpl20-CD4 complex in HeLa cells
We performed experiments to analyse intracellular transport of the CD4 molecules in the absence and presence of the HIV envelope glycoproteins. Such an analysis would also reveal the intracellular processing of CD4 and envelope glycoproteins. Accordingly, HeLa cells were transfected with the plasmid encoding wt CD4 in the absence and presence of gpl20. The transfected HeLa cells were pulse-labelled with 100 gCi/ml [3~S]methionine for 30 min and chased at the indicated times in the presence of excess unlabelled methionine and cysteine. Cytoplasmic lysates were immunoprecipitated with the OKT4 antibody and the proteins were analysed by 8 % SDS-PAGE. To examine the maturation kinetics of CD4 in both singly and cotransfected cells, the immunoprecipitates were treated with Endo-H or left untreated (Jabbar & Nayak, 1990) . The acquisition of Endo-H resistance would indicate that proteins traversed the Golgi apparatus, whereas sensitivity to the enzyme would mean that proteins were localized in the ER (Dunphy & Rothman, 1983; Kornfeld & Kornfeld, 1985) . As shown in Fig. 3(a) , wt CD4 made during the 30 rain pulse-labelling period was sensitive to Endo-H digestion, indicating that the CD4 molecule was translocated into the ER undergoing high mannose oligosaccharide modifications (CD4-CHO). However, during the chase period wt CD4 acquired Endo-H-resistant oligosaccharides indicative of its transport through the Golgi complex (Fig. 3 a; arrowhead b). At 2 h of chase, approximately 90 % of the CD4 molecule had acquired Endo-H resistance, whereas little or no wt CD4 remained Endo-H-sensitive after a 5 h chase period demonstrating an efficient transfer of CD4 to the cell surface. On the other hand, only CD4 molecules were immunoprecipitated by the OKT4 antibody during the 30 min pulse-labelling period in cotransfected cells, and they were sensitive to Endo-H digestion (Fig. 3 b) . After 30min chase, gp120 was coprecipitated with CD4 suggesting that it took about 0"5 to 1 h for CD4 to acquire the ability to bind gpl20 in the ER (Fig. 3b , gpl20-CHO). Moreover, the gpl20 in the complex (Fig.  3 b ; arrowhead a) appeared to undergo further modifications during the chase demonstrating that the gpl20--CD4 complex was competent for transport in the secretory pathway of mammalian cells. Furthermore, the maturation of CD4 in the complex was comparable to that of the CD4 molecule in singly transfected cells (compare Fig. 3 a and b, arrowhead b) . Thus the data demonstrated that the intracellular interaction of wt CD4 with gpl20 did not affect the maturation and transport of gpl20-CD4 complexes in the secretory pathway.
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CD4K3 and gpl20-CD4K3 complexes were retained in the ER
It has been shown that the lysine residues at the -3 or -3 and -4 positions in the carboxyl terminus of type 1 glycoproteins could serve as an ER retention signal (Jackson et al., 1990) . The IF data have demonstrated that CD4K3 bearing the transmembrane ER retention signal (KKTC) was not transported to the cell surface (Fig. 2g) . We therefore wanted to examine the intracellular transport of CD4K3 alone and in combination with gp120 using the pulse-chase protocol described in Methods. Cytoplasmic lysates were immunoprecipitated with the OKT4 antibody and the immunoprecipitates were Endo-H-treated or left untreated to analyse the nature of the oligosaccharide modification on the glycoproteins (Fig. 3 c and d ). CD4K3 made during the pulse-labelling was completely Endo-H-sensitive indicating that the molecule was translocated into the ER undergoing high mannose modifications (Fig. 3 c) . In contrast to wt CD4 (Fig. 3 a) , CD4K3 did not undergo further modifications and remained Endo-H-sensitive throughout the chase period (Fig. 3 c) , demonstrating that the mutant CD4 molecule was effectively retained in the ER due to exposure of the transmembrane ER retention signal (KKTC) at the COOH terminus. Thus the pulse-chase experiments corroborated the indirect IF data (Fig. 2g, h) . In cotransfected cells, CD4K3 formed complexes with gp120 at kinetics very similar to that of wt CD4 (Fig.  3 b, d) , and the gpl20-CD4K3 complexes were immunoprecipitated by the OKT4 antibody (Fig. 3 d) . In contrast to the gpl20-wt CD4 complex that matured to have Endo-H-resistant oligosaccharides (Fig. 3b) , the gpl20-CD4K3 complex remained totally sensitive to Endo-H digestion during the chase period, indicating N. U. Raja, M. J. Vincent and M. A. Jabbar that CD4K3 had interfered with the intracellular transport of gp120 (Fig. 3d) . Thus, CD4K3 interacted with gp120 forming gpl20-CD4K3 complexes which were efficiently retained in the ER. These analyses have clearly demonstrated that both wt CD4 and CD4K3 were able to interact with gpl20 and the interaction took place in the ER. However, productive transport of the gp120-CD4 complexes was dependent on the transport competence of CD4 molecules.
CD4K1 and gpl20-CD4K1 complexes exhibited partial transport defects
The indirect 1F data provided evidence that the mutant CD4 molecule, CD4K1, was present both at the plasma membrane and in the intracellular compartment (Fig.  2c, d ). The IF measures only the steady-state levels of CD4 molecules in the cell and therefore it was not a quantitative method. It has been shown however that the lysine residue at the -3 position at the COOH terminus is sufficient to cause type 1 glycoproteins to be retained in the ER (Jackson et al., 1990) . We therefore performed pulse-chase analysis to study the processing of CD4K1 in the presence and absence of gp120 (Fig. 4a, b) . CD4K1 made during the pulse-labelling was glycosylated as evidenced by its sensitivity to Endo-H digestion (Fig.  4b) . However, during the chase period only a fraction of CD4K1 underwent Endo-H-resistant modifications, which indicated that CD4K1 was severely defective in the intracellular transport. This was in contrast to wt CD4, 90 % of which had acquired Endo-H resistance at a similar chase time ( Fig. 3a and b) . Even after 5 h of chase only a small fraction (approx. 30 %) of CD4K1 was processed to have Endo-H-resistant modifications suggesting that the majority of CD4K1 was retained in the ER (Fig. 4b, arrowhead b) . In cotransfected cells, on the other hand, CD4K1 formed complexes with gpl20 more rapidly than in cells expressing gpl20 and wt CD4 or CD4K3 (compare Fig. 3b and d with Fig. 4a ). As shown in singly transfected cells, CD4K1 was also defective in acquiring Endo-H resistance in cotransfected cells (Fig. 4a) suggesting that the sequence IKRL at the carboxyl terminus was able to retain CD4K1 and the gpl20-CD4K1 complex in the ER at 30% of the efficiency with which CD4K3 or the gp120-CD4K3 complex was retained in the organelle (Fig. 3 c, d ).
CD4K2 and gpl20-CD4K2 complexes were also partially defective in intracellular transport
Thus far we have provided evidence that the intracellular transport of gpl20-CD4 complexes was directly related to the transport competence of CD4 molecules tested in the assay (Fig. 3 and Fig. 4a, b) . The CD4 mutants CD4K3 and CD4K1 have the sequences KKTC and IKRL, respectively, at the carboxyl terminus (Fig. 1) . Of the two mutants, CD4K3 was completely retained in the ER (Fig. 3 c) , whereas CD4K1 exhibited only a partial ER retention phenotype (Fig. 4b) (1991 a) . To examine whether the lysine residues at -2 and -3 could also provide an efficient ER retention signal, we analysed the intracellular processing of CD4K2. Using the IF assay, we have already shown that CD4K2 was targeted to the cell surface, but quantification was not possible in those experiments (Fig. 2e) . We performed pulse-chase analyses to assess the intracellular maturation of CD4K2 in the absence and presence of gpl20 (Fig. 4d, c) . CD4K2 made during the 30 min pulse-labelling was completely sensitive to Endo-H digestion for 0.5 to 1 h, but after 2 h of chase it had acquired Endo-H resistance. After 5 h of chase, nearly 50% of the molecules had undergone Golgi modifications (Fig. 4 c) . Thus the initial delay in the maturation kinetics was due to the retention of CD4K2 in the ER. In cotransfected cells, CD4K2 readily formed complexes with gpl20 during the 30 min pulse-labelling and this was very similar to CD4K1 (compare Fig. 4a with c) . However, more than 50 % of CD4K2 in the complex was Endo-H-resistant after 5 h of chase, indicating that the gpl20-CD4K2 complex was able to traverse the Golgi apparatus. It has been difficult to quantify the Endo-Hresistant gp 120 due to the heterogeneous nature of gp 120 after Endo-H digestion (Fig. 3b , *** in + Endo-H lanes; Jabbar & Nayak, 1990; Crise et al., 1990) . Thus, the data have clearly demonstrated that the lysine residues at positions -2 and -3 in the carboxyl terminus were not sufficient for the efficient retention of CD4 in the ER.
CD4K3 blocked the transport of gpl20/gp41 complexes to the plasma membrane
As shown in Fig. 3 and 4 , the wt or mutant CD4 molecules bearing the transmembrane ER retention signal formed complexes with gpl20, and these complexes were retained in the ER at different efficiencies. To localize gp 160 and gp 120/gp41 complexes in the presence of CD4 molecules, plasmids encoding gpl60, gpl60 and wt CD4, CD4K1, CD4K2 or CD4K3 were introduced into HeLa cells and expression of the HIV envelope glycoproteins was monitored using the anti-gpl20 antibody as described in Methods. As expected, the gpl20 or gpl20/gp41 complex was present at the plasma membrane ( Fig. 5a ) and intracellular membrane compartments (Fig. 5 b) in cells expressing gp 160 alone. However, similar labelling of the cells expressing CD4K3 and gpl60 did not reveal the presence of gpl20 at the cell surface (Fig. 5i) , but intracellular membranes were intensely labelled showing a reticular ER staining pattern (Fig. 5j) . Thus, CD4K3 had interfered with the cell surface transport of gp 120/gp41 complexes and retained them in the ER.
Furthermore, the anti-gp120 antibody labelled gpl20 or gpl20/gp41 complexes at the plasma membrane, as well as in the intracellular compartment of the HeLa cells expressing gpl60 and wt CD4 (Fig. 5c, d ), gpl60 and CD4K1 (Fig. 5e, f) , or gpl60 and CD4K2 (Fig. 5g, h) . However, the cell surface labelling of gpl20 in cotransfected cells (Fig. 5c, e, g ) was appreciably diminished compared to those expressing gpl60 alone (Fig. 5a ). This was perhaps due to a partial retention of the gpl20/gp41 complex in the ER or masking of epitopes in the gpl20/gp41 complex. We showed that both CD4K1 and CD4K2 exhibit partial ER retention phenotypes (Fig.  4) . Even though CD4 was transport-competent and did not affect the intracellular transport of gpl20 (Fig.  3a, b) , the surface intensity of gpl20 in cells expressing gpl60 and wt CD4 (Fig. 5c ) was very similar to that observed for cells expressing gp160 and CD4K1 (Fig. 5 e) or gpl60 and CD4K2 (Fig. 5g) . We used a polyclonal antibody (against gpl20sr2), and therefore it is possible that CD4 in the gpl20/gp41-CD4 complex might have masked some epitopes in gpl20, resulting in the reduced labelling by the antibody. However, we clearly demonstrated that CD4K3 having the lysine residues at the -3 and -4 positions in the carboxyl terminus (KKTC) was capable of interfering with the transport of gpl20 or gpl20/gp41 complexes in the secretory pathway. Thus, proteins were transfected into HeLa cells and immunolabelled as described in Methods. The gp120 antibody was used to localize the envelope glycoprotein at the cell surface (a, c, e, g, i) and in the intracellular compartment (b, d,f, h,j) . Cells expressing gpl60 alone (a, b); cells expressing both gpl60 and wt CD4 (c, d); cells expressing both gpl60 and CD4K1 (e,f); cells expressing gp160 and CD4K2 (g, h); cells expressing gpl60 and CD4K3 (i,j).
the transport inhibition was primarily due to the retention of gpl20-CD4K3 or gpl20/gp41-CD4K3 complexes in the ER (Fig. 3c, d and 5i, j).
Endoproteolytic cleavage of the H I V envelope glycoprotein precursor, gpl60, in the presence of CD4 molecules
It has been shown previously that the endoproteolytic cleavage of gp 160 can occur normally in cells expressing gpl60 and CD4, and the gpl20/gp41 complex was transported to the cell surface as evidenced by the shedding of gpl20 into the medium (Jabbar & Nayak, 1990) . To examine the intracellular processing and endoproteolytic cleavage of gpl60 in the presence of CD4 molecules, the plasmids encoding gpl60 and wt CD4, CD4K1, CD4K2 or CD4K3 were transfected into HeLa cells and expression was analysed. The transfected HeLa cells were pulse-labelled with 100 ~tCi/ml [~SS]methionine and cytoplasmic lysates were immunoprecipitated with the OKT4 antibody. Protein complexes were resolved by 8 % SDS-PAGE. Fig. 6 shows the formation of gpl60-CD4 complexes in the cell, as well as gpl20 shedding into the medium. In cells expressing gpl60 and wt CD4, the CD4 molecule was coprecipitated with gpl60 during the 30min pulselabelling period and the gp 160-CD4 complex was Endo-H-sensitive (gpl60 minus CHO) indicating that the complex formation had occurred in the ER. However, during the chase period (2.5 h) a fraction of the complex appeared to mature as evidenced by the Endo-H-resistant CD4 molecule in the complex. This coincided with the appearance of gpl20 (gpl20 minus CHO), suggesting that the gp 160 in the complex underwent endoproteolytic cleavage and further suggested that the gpl20/gp41-CD4 complex was transport-competent. However, digestion of the complex with Endo-H did not reveal distinct deglycosylated gp 120, as only a fraction of gp 160 was cleaved to generate gpl20 and gp41 (Jabbar & Nayak, 1990) . After 5 h of the chase period, however, there was a reduction in the intracellular gpl20 due to the cell surface transport and shedding of gpl20 into the medium (Fig. 6a , gpl20 plus CHO; Fig. 6c ).
In cells expressing gpl60 and CD4K1, the mutant CD4 molecule was immunoprecipitated with gpl60 during the pulse-labelling period (Fig. 6 a) . As shown for wt CD4, the gpl60-CD4K1 complex remained Endo-Hsensitive at the point of labelling, and a fraction of CD4K1 in the complex became Endo-H-resistant after the chase period, very similar to what was observed in cells expressing gpl60 and wt CD4 (Fig. 6a, lanes with Endo-H). Furthermore, the maturation of CD4K1 in the complex coincided with the appearance of gpl20 after 2.5 h of chase in cotransfected cells (Fig. 6a) , suggesting Cytoplasmic extracts were immunopreeipitated with the OKT4 antibody, whereas the gpl20 antibody was used to detect the shedding ofgpl20 into the medium. The gpl20 was analysed on 8 % SDS-PAGE gels without Endo-H treatment. The immunoprecipitates obtained from cytoplasmic lysates were either treated with Endo-H ( + ) or left untreated ( -) , and analysed by 8% SDS PAGE (Jabbar & Nayak, 1990 ). M, M r markers. that the gp160 in the complex was endoproteolytically cleaved into gpl20 and gp41. This was also evident from the analysis of media from cells expressing gp160 and CD4K1, and the gpl20 was detected in the medium with
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We have also analysed the complex formation, endoproteolytic processing and gpl20 shedding in cells expressing gpl60 and CD4K2, or CD4K3 ( Fig. 6b ; gpl60 plus CD4K2, gpl60 plus CD4K3). The complex formation between gp 160 and the mutant CD4 molecules was essentially unchanged. However, gpl60 was not efficiently coprecipitated with CD4K2 during the pulse time as compared to cells expressing gpl60 and CD4K1 (compare Fig. 6a with b) . Furthermore, CD4K2 in the complex remained Endo-H-sensitive throughout the chase period and the gp120 was not precipitated by the OKT4 antibody. This was in contrast to that observed in cells expressing gpl60 and CD4, or CD4K1 (Fig. 6a) . It is possible, however, that the transport-competent intracellular gp120/gp41-CD4K2 complex was so labile in detergent lysates that the OKT4 antibody was not able to precipitate the complex. However, the gpl20 was detected in the medium, suggesting that the gp120/gp41 complex was transported to the cell surface and a fraction of gpl20 was subsequently shed into the medium ( Fig.  6c; gp160 plus CD4K2) .
Furthermore, the pulse--chase analysis of cells expressing gp160 and CD4K3 revealed that CD4K3 could form complexes with gpl60 as readily as could wt CD4 (Fig. 6b) . During the chase period, gpl20 was generated in the intracellular compartment and remained cellbound even after the 5 h chase period (Fig. 6b, gpl60 plus CD4K3 ; gp 120 plus CHO). As expected, CD4K3 in the complex was Endo-H-sensitive during the pulse and throughout the chase periods due to the retention of CD4K3 and gpl20/gp41-CD4K3 complexes in the ER. Consequently, the intracellular gp120 was not delivered to the cell surface as evidenced by the lack of gpl20 in the medium (Fig. 6c, gpl60 plus CD4K3 ). Thus these analyses have shown that the CD4 molecule bearing the transmembrane ER retention signal (KKTC) was able to sequester both gp160 and gp120/gp41 complexes in the ER, thereby blocking the delivery of gp120 to the cell surface.
The formation of syncytia in single and cotransfected cells
Both immunochemical and biochemical analyses have shown that CD4K3 interfered with the cell surface delivery of gpl20 ( Fig. 5i and 6b) , whereas wt CD4, CD4K1 and CD4K2 did not appreciably affect the transport of gpl20/gp41 complex to the plasma membrane (Fig. 5c, e,g and 6c) . To test whether the gpl20/gp41 complex at the surface of cotransfected cells could participate in membrane fusion events, plasmids (5 gg) encoding gpl60 alone or in combination
The fusion inhibition might not be solely due to the absence of gpl20/gp41 complexes at the surface of cotransfected cells, as the anti-gpl20 antibody could stain the gpl20 molecule at the plasma membrane (Fig.  5c, e, g ) and the gpl20 was shed into the medium (Fig.  6c, gpl60 plus CD4 , CD4K1 or CD4K2). As expected, no syncytia were observed in HeLa T4 cells infected with vTF7-3 (Fig. 7f) . with those (5 gg each) that encode one of the four CD4 proteins (wt CD4, CD4K1, CD4K2 or CD4K3) were transfected into HeLa T4 cells and syncytia were observed at 15 to 20 h post-infection (Fig. 7) . The gpl60 induced the formation of syncytia in HeLa T4 cells (Fig.  7a) , whereas cells expressing gp160 and CD4K3 were not able to form a polykaryon (Fig. 7e) . The lack of envelope-mediated membrane fusion appears therefore to be due primarily to the retention of gpl20/gp41 complexes in the ER (Fig. 6b, gpl60 plus CD4K3) as little or no gp120 was detected in the medium (Fig. 6c) or at the surface of cotransfected cells (Fig. 5/) . Interestingly, however, the formation of syncytia was also appreciably reduced in cells expressing gp 160 and wt CD4 (Fig. 7b) , CD4K1 (panel c) or CD4K2 (panel at).
Discussion
In the present study, we analysed processing of the HIV envelope glycoprotein, as well as envelope-mediated membrane fusion in the presence of wt CD4 or mutant CD4 molecules bearing the transmembrane ER retention signals. We have presented evidence that the transport of gpl20 CD4 complexes in the secretory pathway was comparable to the transport kinetics of wt CD4, CD4K1, CD4K2 or CD4K3 when these were expressed alone, suggesting that intracellular movement of the complex is dependent on the transport-competence of CD4 molecules. The intracellular transport kinetics of gp 120-CD4 complexes (Fig. 3 b) was in agreement with the experiments of Crise et al. (1990) . It was demonstrated that gpl20 and wt CD4 interacted with each other forming complexes in the ER and the complex could move to the Golgi apparatus. Furthermore, we have shown that gp160 made in the presence of CD4K3 was endoproteolytically cleaved generating gpl20/gp41, and the intracellular gp120 was not transported to the cell surface as evidenced by the lack of gpl20 shedding into the medium (Fig. 6b, c) . Recent evidence suggests that the transmembrane proteins with lysine residues at the -3 and -4 positions could be retrieved from a membrane compartment that includes the cis-Golgi network (Rothman & Orci, 1992; Jackson et al., 1993) . Therefore, it is likely that the endoproteolytic cleavage of gp 160 had occurred in the ER or cis-Golgi network. In support of this conclusion, we have demonstrated that a chimeric envelope glycoprotein comprising the ectodomain of gp160 and the anchor/cytoplasmic domains of CD4K3 (Env-CD4K3AC) was retained in the ER undergoing endoproteolytic cleavage and gp120 was transported to the cell surface, albeit very inefficiently (Vincent et al., 1993) .
Biochemical analyses of the HIV envelope glycoprotein precursor, gpl60, have elucidated the intracellular membrane compartment(s) in which gpl60 undergoes endoproteolytic cleavage in the secretory pathway of mammalian cells (Willey et al., 1988; Geyer et al., 1988; Dewar et al., 1989; Stein & Engleman, 1990; Earl et al., 1991) . Stein & Engleman (1990) provided evidence that the endoproteolytic cleavage of gpl60 could occur in the region of rough ER-Golgi complex (cis-Golgi) where the activity of ~-mannosidase I is presumably localized (Dunphy & Rothman, 1983; Kornfeld & Kornfeld, 1985) . However, the kinetic and quantitative analysis of the envelope glycoprotein demonstrated that the cleavage of gpl60 closely approximated the acquisition of Endo-H-resistance and, hence, the cleavage occurred in the medial or trans-Golgi region of the cell (Earl et al., 1991) . In the present study, we have provided evidence that the endoproteolytic cleavage of gpl60 occurred in the membrane compartment where CD4K3 was retained, most likely the ER or cis-Golgi network. Furthermore, the present studies have demonstrated that the retention approach could have a general application in the elucidation of biochemical processes that are important in the maturation of glycoproteins traversing the secretory pathway of eukaryotic cells. Genetic and biochemical characterization of the endoproteases would help elucidate localization and functional reconstitution of the enzymes that cleave precursor proteins (e.g. gpl60) in the secretory pathway of mammalian cells (Barr, 1991) .
The present analysis did not allow us to demonstrate whether gpl20 or gpl20/gp41 complex was defective in the intracellular transport in cells expressing gp160 and CD4K3. It is likely that gpl20 and gp41 move as a complex to the plasma membrane, and CD4K3 binds the complex in the ER preventing it from being targeted to the cell surface. It is also possible that gpl20 and gp41 move through the secretory pathway independently of each other. CD4K3 binds gpl20 in the gpl20/gp41 complex involving the receptor binding domains and retains it in the ER without appreciably interfering with the movement of gp41 to the cell surface. The gp41 is a cell-associated molecule and our analysis did not reveal whether it was anchored to the ER or plasma membrane of the cells expressing gpl60 and CD4K3. However, analysis of the chimeric envelope glycoprotein, Env-CD4K3AC, has suggested that the gpl20/TM glycoprotein component could perhaps move as a complex to the plasma membrane (Vincent et al., 1993) .
Our observation that the generation and delivery of gpl20 to the cell surface could occur in cells expressing gpl60 and wt CD4 differed in some aspects from the studies of Willey et al. (1992a) . The authors demonstrated that wt CD4 could block the endoproteolytic cleavage of gpl60, and VPU (the vpu gene product) relieved the block by decreasing the steady-state levels of CD4 by mechanism(s) not understood at present. Our studies show that the wt or mutant CD4 molecules with the lysine residue at position -3 (partial ER retention) do not appreciably interfere with the endoproteolytic cleavage of gpl60. It is likely that the vaccinia virusbased expression system used in our analysis did not reveal the properties of CD4 that are dependent on the expression levels of the protein. However, the CD4 molecule (CD4K3) having the lysine residues at positions -3 and -4 (full ER retention) could effectively interfere with the delivery of gpl20 to the plasma membrane, suggesting that the retention of CD4K3, gpl60-CD4K3 and gpl20/gp41-CD4K3 complexes in the ER is not affected in vaccinia virus-infected cells. Buonocore & Rose (1990) have shown that the sCD4 bearing the luminal ER retention signal (sCD4-KDEL) interferes with the transport of gpl20/gp41 complexes to the cell surface, thereby preventing the envelope-mediated membrane fusion. In this report, we have demonstrated that the CD4 molecule bearing the transmembrane ER retention signal (KKTC) could effectively interfere with the envelope-mediated membrane fusion primarily due to the retention of the gpl20/gp41 complex in the intracellular compartment ( Fig. 5j and 6b) .
Furthermore, the formation of syncytia was also appreciably reduced in cells expressing gpl60 and wt CD4, CD4K1 or CD4K2 (Fig. 7b, c, d ). The mechanism(s) by which the inhibition of membrane fusion is brought about by the CD4 molecules is not clearly understood at present. However, the gp 120 was delivered to the plasma membrane of cells expressing gp 160 and wt CD4, CD4K1 or CD4K2 (Fig. 5c, e, g ), and gpl20 was shed into the medium (Fig. 6c) . Therefore the fusion inhibition mediated by the CD4 molecules might not be due to the lack of gpl20 at the cell surface. It is possible that the formation of complexes of gpl20 with CD4 at the cell surface of co-expressing cells might saturate the CD4-binding sites on the gpl20 molecule so that CD4 at the plasma membrane of target cells (HeLa T4) could not compete, resulting in the fusion inhibition phenotype. Interestingly, Buonocore & Rose (1990) reported that sCD4 was able to block the formation of syncytia partially when it was expressed together with gp 160, and they suggested that this could be due to a partial saturation of the CD4-binding site on the gpl20/gp41 complex.
Other factors might also influence membrane fusion properties of HIV-1 gpl60 in co-expressing cells. The indirect IF data show that the intensity of the gpl20 labelling was diminished in cells expressing gp160 and wt CD4 (Fig. 5c), CD4K1 (Fig. 5e) or CD4K2 (Fig. 5g) , compared to those expressing gpl60 alone (Fig. 5a ). This could partly explain the reduction in the formation of syncytia in cotransfected cells (Fig. 7b, c,d ). The gpl20-CD4 interactions are crucial to the establishment of HIV pathogenesis and, hence, more detailed analyses using the ER-retained CD4 mutants might shed light on the complex nature of their intracellular interactions in mammalian cells. Recently, Buonocore & Rose (1993) have provided evidence that the expression of sCD4-KDEL completely blocked the production of infectious HIV particles and no virus spread was noticeable in HIV-infected lymphoid CD4 ÷ cells, Furthermore, the block in virus spread was due to the trapping of gpl20/gp41 complexes in the ER and the virus-infected cells were gradually eliminated from the culture. Thus the ER retention strategy has a potential application in gene therapy approaches to control the spread of HIV infection in susceptible individuals.
